相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evidence for the existence of FGFR1-5-HT1A heteroreceptor complexes in the midbrain raphe 5-HT system
Dasiel O. Borroto-Escuela et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Antidepressant actions of ketamine: from molecular mechanisms to clinical practice
Lisa M. Monteggia et al.
CURRENT OPINION IN NEUROBIOLOGY (2015)
Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome
Sebastian H. Scharf et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Metabotropic glutamate receptors as drug targets: what's new?
Ferdinando Nicoletti et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators: Discovery of 2-Chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyllpyridine (Basimglurant, R04917523), a Promising Novel Medicine for Psychiatric Diseases
Georg Jaeschke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
An excitatory synapse hypothesis of depression
Scott M. Thompson et al.
TRENDS IN NEUROSCIENCES (2015)
Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease
Kjell Fuxe et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
G-protein-coupled receptor type A heteromers as an emerging therapeutic target
Diego Guidolin et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
On the role of adenosine (A)(2A) receptors in cocaine-induced reward: a pharmacological and neurochemical analysis in rats
Karolina Wydra et al.
PSYCHOPHARMACOLOGY (2015)
Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation
Karen J. Gregory et al.
MOLECULAR PHARMACOLOGY (2015)
Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Mavoglurant as a treatment for Parkinson's disease
Dmitry Petrov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
The G Protein-Coupled Receptor Heterodimer Network (GPCR-HetNet) and Its Hub Components
Dasiel O. Borroto-Escuela et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain
Andrew S. Dore et al.
NATURE (2014)
Development of allosteric modulators of GPCRs for treatment of CNS disorders
Hilary Highfield Nickols et al.
NEUROBIOLOGY OF DISEASE (2014)
A Whole-Brain Atlas of Inputs to Serotonergic Neurons of the Dorsal and Median Raphe Nuclei
Iskra Pollak Dorocic et al.
NEURON (2014)
Moonlighting Proteins and Protein-Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field
Kjell Fuxe et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Mice Lacking NMDA Receptors in Parvalbumin Neurons Display Normal Depression-Related Behavior and Response to Antidepressant Action of NMDAR Antagonists
Laura Pozzi et al.
PLOS ONE (2014)
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2013)
Neurotransmitter Targeting in the Treatment of Depression
Pierre Blier
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Differential regulation of CaMKIIα interactions with mGluR5 and NMDA receptors by Ca2+ in neurons
Dao-Zhong Jin et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
Elena Nosyreva et al.
JOURNAL OF NEUROSCIENCE (2013)
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Mauro Costa-Mattioli et al.
NATURE NEUROSCIENCE (2013)
mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons
Maria Teresa Dell'Anno et al.
NEUROPHARMACOLOGY (2013)
mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
Shigeyuki Chaki et al.
NEUROPHARMACOLOGY (2013)
Monoamine neurocircuitry in depression and strategies for new treatments
Michel Hamon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling
M. J. Noetzel et al.
MOLECULAR PHARMACOLOGY (2013)
Fibroblast Growth Factor Receptor 1-5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity
Dasiel O. Borroto-Escuela et al.
BIOLOGICAL PSYCHIATRY (2012)
Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders
Gerard Sanacora et al.
NEUROPHARMACOLOGY (2012)
METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONIST 2-METHYL-6-(PHENYLETHYNYL)PYRIDINE PRODUCES ANTIDEPRESSANT EFFECTS IN RATS: ROLE OF BRAIN-DERIVED NEUROTROPHIC FACTOR
C. Y. Liu et al.
NEUROSCIENCE (2012)
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman et al.
SCIENCE (2012)
Distribution of Extrasynaptic NMDA Receptors on Neurons
Ronald S. Petralia
SCIENTIFIC WORLD JOURNAL (2012)
Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks
Kjell Fuxe et al.
FRONTIERS IN PHYSIOLOGY (2012)
Reduced Metabotropic Glutamate Receptor 5 Density in Major Depression Determined by [11C]ABP688 PET and Postmortem Study
Alexandra Deschwanden et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain
Valeria Tronci et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization
Dasiel O. Borroto-Escuela et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders
A. Gravius et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator
Holger Rosenbrock et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis
Miguel Perez de la Mora et al.
PROGRESS IN NEUROBIOLOGY (2010)
Efficacy and Effectiveness of Antidepressants: Current Status of Research
H. Edmund Pigott et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2010)
Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells
Nuria Cabello et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Neuroimaging and Physiological Evidence for Involvement of Glutamatergic Transmission in Regulation of the Striatal Dopaminergic System
Masaki Tokunaga et al.
JOURNAL OF NEUROSCIENCE (2009)
Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the μ-opioid receptor
H. Schroeder et al.
NEUROPHARMACOLOGY (2009)
The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning
Wolfgang Jacob et al.
NEUROPHARMACOLOGY (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Mood disorders: Regulation by metabotropic glutamate receptors
Andrzej Pilc et al.
BIOCHEMICAL PHARMACOLOGY (2008)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Important messages in the 'post':: recent discoveries in 5-HT neurone feedback control
Trevor Sharp et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Positive allosteric modulation of metabotropic glutarnate 5 (rnGlu5) receptors reverses N-methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex
Lucas Lecourtier et al.
BIOLOGICAL PSYCHIATRY (2007)
From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication:: Wiring and volume transmission
Kjell Fuxe et al.
BRAIN RESEARCH REVIEWS (2007)
ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors:: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies
Samuel Hintermann et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice
Xia Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes
YQ Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Functional interaction between NMDA and mGlu5 receptors: Effects on working memory, instrumental learning, motor behaviors, and dopamine release
H Homayoun et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons
LF Agnati et al.
PHARMACOLOGICAL REVIEWS (2003)
Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors:: Implications for striatal neuronal function
S Ferré et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus
M Smialowska et al.
NEUROPHARMACOLOGY (2002)
Heterodimerization of calcium sensing receptors with metabotropic glutamate receptors in neurons
L Gama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The selective mGlu5 receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D2 receptors in the rat striatum -: Interactions with adenosine A2a receptors
P Popoli et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Metabotropic glutamate autoreceptors of the mGlu(5) subtype positively modulate neuronal glutamate release in the rat forebrain in vitro
LS Thomas et al.
NEUROPHARMACOLOGY (2000)
分享论文
